Ignite Creation Date:
2024-05-05 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00699816
Status:
COMPLETED
Last Update Posted:
2023-07-11
First Post:
2008-06-17
Brief Title:
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
Sponsor:
GC Cell Corporation
Organization:
GC Cell Corporation
Study Overview
Official Title:
Randomized Open-label Multi-center and Phase 3 Clinical Trial to Compare the Efficacy and Safety of Green Cross CELL Immuncell-LC Group and Non-treatment Group in Patient Undergone Curative ResectionPEIT RFA or Operation for Hepatocellular Carcinoma in Korea
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To prove that the efficacy and safety of Green Cross CELL Immuncell-LC group is superior to non-treatment groupControl group in patient undergone curative resectionPEIT RFA or operation for hepatocellular carcinoma in Korea
Detailed Description:
Multicenter randomized open-labeled phase 3 clinical trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None